Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
!!Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Preservation of cell-based immunotherapies for clinical trials
Rui Li
, Rachel Johnson
, Guanglin Yu
,
David H. McKenna
,
Allison Hubel
Mechanical Engineering
Laboratory Medicine and Pathology
Transplant and Cellular Therapy
Research output
:
Contribution to journal
›
Review article
›
peer-review
91
!!Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Preservation of cell-based immunotherapies for clinical trials'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Trials
100%
Cell-based
100%
Cellular Immunotherapy
100%
Dimethyl Sulfoxide
100%
Cell Viability
66%
Cell Therapy
66%
Natural Killer Cells
66%
Cryopreservation
66%
Cryoprotectant
66%
Cooling Rate
66%
Freezing Medium
66%
Plasma/serum
66%
T Cells
33%
Clinical Application
33%
Supply Chain
33%
Dendritic Cells
33%
Chimeric Antigen Receptor T Cells (CAR-T)
33%
Cryopreserved
33%
Cellular Products
33%
Improvement Methods
33%
Gamma delta T Cells
33%
Storage Conditions
33%
Water Bath
33%
Cultured Cells
33%
Cytotoxic Activity
33%
Preservation Methods
33%
Saccharides
33%
Human Serum Albumin
33%
Carrier Solution
33%
Emerging Approaches
33%
Cryopreserved Cells
33%
Cell Functionality
33%
Given Information
33%
Controlled-rate Freezer
33%
Free Formulation
33%
Freezing Process
33%
Thawing Conditions
33%
Veterinary Science and Veterinary Medicine
Natural Killer Cell
100%
Cryopreservation
100%
Chimeric Antigen Receptor
50%
T Cell
50%
Dendritic Cell
50%
Human Serum Albumin
50%
Gamma Delta T Cell
50%
Blood Plasma
50%
Carbohydrate
50%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Immunotherapy
100%
Dimethyl Sulfoxide
75%
Cell Viability
50%
Cryoprotective Agent
50%
Chimeric Antigen Receptor
25%
Human Serum Albumin
25%
Carbohydrates
25%
Immunology and Microbiology
Immunotherapy
100%
Natural Killer Cell
50%
Cell Viability
50%
Cryopreservation
50%
Dendritic Cell
25%
Blood Plasma
25%
Serum (Blood)
25%
Gamma Delta T Cell
25%
Chimeric Antigen Receptor
25%
T Cell
25%
Albumin
25%